Not Signed In -
Cirrhosis |
Cirrhosis (Primary Biliary); Cirrhosis of the Liver; Liver Cirrhosis |
Clinical Trial: Phase I Study of Colchicine Therapy in Childhood Hepatic Cirrhosis
This study is no longer recruiting patients.
|
Purpose
OBJECTIVES: I. Investigate the efficacy and safety of colchicine therapy in improving hepatic function and reducing hepatic fibrosis (scarring) in children with hepatic cirrhosis.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Cirrhosis Liver Cirrhosis | Drug: colchicine | Phase I |
MedlinePlus related topics: Cirrhosis
Study Type: Interventional
Study Design: Treatment
Further Study Details:
Expected Total Enrollment: 15
Study start: May 1990
PROTOCOL OUTLINE: Patients receive colchicine orally twice daily for 24 months. After the first month, the dose of colchicine will increase and remain at that dose for the duration of study. Patients are evaluated every 6 months during study.
Eligibility
Ages Eligible for Study: up to 17 Years, Genders Eligible for Study: Both
Criteria
Location Information
Study chairs or principal investigators
Ronald J. Sokol, Study Chair, Children's Hospital Denver
More Information
Study ID Numbers: 199/11947; CHD-1089
Record last reviewed: October 2003
Last Updated: October 13, 2004
Record first received: October 18, 1999
ClinicalTrials.gov Identifier: NCT00004368
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Record last reviewed: October 2003
Last Updated: October 13, 2004
Record first received: October 18, 1999
ClinicalTrials.gov Identifier: NCT00004368
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
email this page
print this page
bookmark this page
feedback on this page
